Pasar al contenido principal

PAPEL DE LA CALCINEURINA VASCULAR EN EL DESARROLLO DE LA HIPERTENSION ARTERIAL Y LOS ANEURISMAS AORTICOS

PID2020-115217RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kidins220 sets the threshold for survival of neural stem cells and progenitors to sustain adult neurogenesis

  • Puerto, Ana del
  • Lopez-Fonseca, Coral
  • Simón-García, Ana
  • Martí-Prado, Beatriz
  • Barrios-Muñoz, Ana L.
  • Pose-Utrilla, Julia
  • López-Menéndez, Celia
  • Alcover-Sanchez, Berta
  • Cesca, Fabrizia
  • Schiavo, Giampietro
  • Campanero, Miguel R.
  • Fariñas, Isabel
  • Iglesias, Teresa
  • Porlan, Eva
17 Pág., In the adult mammalian brain, neural stem cells (NSCs) located in highly restricted niches sustain the generation of new neurons that integrate into existing circuits. A reduction in adult neurogenesis is linked to ageing and neurodegeneration, whereas dysregulation of proliferation and survival of NSCs have been hypothesized to be at the origin of glioma. Thus, unravelling the molecular underpinnings of the regulated activation that NSCs must undergo to proliferate and generate new progeny is of considerable relevance. Current research has identified cues promoting or restraining NSCs activation. Yet, whether NSCs depend on external signals to survive or if intrinsic factors establish a threshold for sustaining their viability remains elusive, even if this knowledge could involve potential for devising novel therapeutic strategies. Kidins220 (Kinase D-interacting substrate of 220 kDa) is an essential effector of crucial pathways for neuronal survival and differentiation. It is dramatically altered in cancer and in neurological and neurodegenerative disorders, emerging as a regulatory molecule with important functions in human disease. Herein, we discover severe neurogenic deficits and hippocampal-based spatial memory defects accompanied by increased neuroblast death and high loss of newly formed neurons in Kidins220 deficient mice. Mechanistically, we demonstrate that Kidins220-dependent activation of AKT in response to EGF restraints GSK3 activity preventing NSCs apoptosis. We also show that NSCs with Kidins220 can survive with lower concentrations of EGF than the ones lacking this molecule. Hence, Kidins220 levels set a molecular threshold for survival in response to mitogens, allowing adult NSCs growth and expansion. Our study identifies Kidins220 as a key player for sensing the availability of growth factors to sustain adult neurogenesis, uncovering a molecular link that may help paving the way towards neurorepair., This work was funded by grants RYC2014-15991 (MINECO/ESF), SAF2015-67756-R (MCIN/AEI /10.13039/501100011033 and by ERDF “A way of making Europe") and PID2019-104763RB-I00 to EP, PID2020-115218RB-I00 to TI, PID2020-117937GB-I00 to IF, PID2020-115217RB-I00 to MRC, funded by MCIN/AEI/ 10.13039/501100011033; by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) and collaborative grants CIBERNED-2015-2/06 and 2018/06 to TI and IF; by PROMETEO/2021/028 of Generalitat Valenciana to IF; by Wellcome Senior Investigator Awards (107116/Z/15/Z and 223022/Z/21/Z) and a UK Dementia Research Institute Foundation award (UKDRI-1005) to GS. ADP was supported by grant FJCI-2014-19673 funded by MCIN/AEI/ 10.13039/501100011033 and by ESF “Investing in your future”; and a CIBERNED contract; AS-G was supported by a contract associated to PID2020-115218RB-I00 project; EP was supported by a Ramón y Cajal contract (RYC2014-15991, MINECO/ESF), ALB-M by grant FPI BES-2016-078481 associated to SAF2015-67756-R to EP. JP-U was supported by a CIBERNED contract. CLF is recipient of a FPI grant funded by UAM. The cost of this publication has been paid in part by “ERDF A way of making Europe” funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation

  • Ruiz-Rodríguez, María Jesús
  • Oller, Jorge
  • Martínez-Martínez, Sara
  • Alarcón-Ruiz, Iván
  • Toral, Marta
  • Sun, Yilin
  • Colmenar, Ángel
  • Méndez-Olivares, María José
  • López-Maderuelo, Dolores
  • Kern, Christine B.
  • Nistal Herrera, Juan Francisco
  • Evangelista, Arturo
  • Teixido-Tura, Gisela
  • Campanero, Miguel R.
  • Redondo, Juan Miguel
The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), the CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO and CNIC are Severo Ochoa Centers of Excellence (grants CEX2021-001154-S and CEX2020-001041-S, respectively) funded by MICIN/AEI/10.13039/501100011033. The project leading to these results has received funding from “La Caixa” Banking Foundation under project codes HR18-00068 (to MRC and JMR); Spanish Ministerio de Ciencia e Innovación grant RTI2018-099246-BI00 (MICIU/AEI/FEDER, UE) to JMR, and grants PID2020-115217RB-100 and PID2021-122388OB-100 to MRC and JMR, respectively, funded by MCIN/AEI/10.13039/501100011033; Instituto de Salud Carlos III (CIBER-CV CB16/11/00264 and CB16/11/00479; and grants PI17/00381 to GT-T and PI21/00084 (co-funded by Fondo Europeo de Desarrollo Regional (FEDER)) to JFN); Fundacio La Marato TV3 (20151330 to JMR); Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL) (INNVAL 21/24) to JFN; The Marfan Foundation USA Faculty grant 2017 MRF/1701 (to JMR); Fundación MERCK; Fundación Española de Enfermedades Raras 2022 and V-Ayudas “Muevete por los que no pueden 2021” (to JO); and Spanish Ministerio de Ciencia e Innovación contracts FPI (BES-2016-077649) to MJR-R; Sara Borrell (CD18/00028) and Juan de la Cierva (IJC2020-044581-I) to MT; Ramón y Cajal (RYC2021-033343-I) to JO; and FPU (20/04814) to IA-R.